]>
IRCT20231001059577N1 IRCT 2024-01-18 University of Kurdistan The effectiveness of unified transdiagnostic treatment on body dysmorphic disorder comorbid with emotional disorders The effectiveness of unified transdiagnostic treatment on emotional, cognitive, and neuropsychological symptoms and indicators in individuals with body dysmorphic disorder comorbid with emotional disorders: A clinical trial study 2024-01-25 anticipated 34 Complete https://irct.ir/trial/72915 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After the people with body dysmorphic disorder comorbid with emotional disorders were selected based on the inclusion and exclusion criteria, they will be allocated to two equal groups of treatment and control using the blocking randomization method. The coin toss method will be used to allocate people in each of the groups (Treatment and control). The blocking method will be used to balance the number of samples assigned to each of the study groups, Blinding description: In this study, a clinical interview will be conducted by a clinical expert therapist to evaluate the inclusion and exclusion criteria. After obtaining informed consent to participate in the research, the participants will be randomly assigned to groups (treatment and control groups), in such a way that the participants have no knowledge of which group (treatment group or control group) they will be placed in. will not have Allocating participants in groups and taking the tests of this research in all three stages (Pre-treatment; post-treatment; follow-up) will be done by someone other than the therapist. N/A body dysmorphic disorder comorbid with emotional disorders. Intervention 1: Intervention group: group 1: UP group. Unified protocol for transdiagnostic of emotional disorders consists of a maximum of 10, 45-minute individual treatment sessions. The UP targets and regulates emotional experiences by increasing emotion awareness and cognitive flexibility; identifying emotion-driven behaviors (EDBs) and replacing them with adaptive behaviors; identifying and preventing patterns of emotion avoidance; increasing awareness and confronting physical sensations, and facing emotions in situations. The treatment is preceded by enhancing the motivation and readiness of individuals for change and treatment engagement. Finally, the treatment ends by considering the progress of treatment and developing relapse prevention strategies. Intervention 2: Control group: wait-list group for Unified protocol.َAfter completion of follow-up sessions of intervention groups, the UP treatment will be applied as intervention group 1. Yes - There is a plan to make this available What will be shared: Part of the data including information about the main consequence can be shared. When: Start of accessibility will be one year after printing the results. To whom: Data will only be available to researchers working in academic institutions. Conditions: Requests for data are only permitted for intercultural studies or the studies of meta-analysis. Where to obtain: Researchers can use the mentioned communication channel to receive the desired documents or data. Email: nasiri.uok@yahoo.com How to obtain: Data will be provided by email or post after evaluation of the request. Comments:
public Fateme Etaati
Pasdaran Blvd; University of Kurdistan
Sanandaj Iran (Islamic Republic of) 66177-15175 087-33664600-8 fateme.etaati@uok.ac.ir University of Kurdistan scientific Farzad Nasiri
Pasdaran Blvd; University of Kurdistan
Sanandaj Iran (Islamic Republic of) 66177-15175 087-33664601-2246 nasiri.uok@yahoo.com University of Kurdistan Iran (Islamic Republic of) Diagnosis of BDD disorder according to DSM-5 Having a minimum score of 53 in the body image concern inventory of Littleton et al The presence of at least one emotional disorder Age range of people from 18 to 45 years Willing to participate in the study by signing a written consent form The ability to speak Persian in all assessments Not having serious mental disorders such as psychosis, bipolar type I or II Not having suicidal thoughts No abuse of benzodiazepines, antipsychotics, and SSRI medicines in the last 6 months 18 years 45 years Both Need for medical intervention Receiving psychotherapy sessions at the same time Concerns about weight-related eating disorders Unwillingness to continue participating at any time in the study Absence of more than 3 sessions in treatment sessions F45.22 Body dysmorphic disorder Treatment - Other Treatment - Other Intervention group: group 1: UP group. Unified protocol for transdiagnostic of emotional disorders consists of a maximum of 10, 45-minute individual treatment sessions. The UP targets and regulates emotional experiences by increasing emotion awareness and cognitive flexibility; identifying emotion-driven behaviors (EDBs) and replacing them with adaptive behaviors; identifying and preventing patterns of emotion avoidance; increasing awareness and confronting physical sensations, and facing emotions in situations. The treatment is preceded by enhancing the motivation and readiness of individuals for change and treatment engagement. Finally, the treatment ends by considering the progress of treatment and developing relapse prevention strategies. Control group: wait-list group for Unified protocol.َAfter completion of follow-up sessions of intervention groups, the UP treatment will be applied as intervention group 1. Score of Body Image Concern from BICI questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Body Image Concern Inventory. Score of depression and Anxiety from DASS-21 questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: DASS-21 questionnaire. Score of cognitive fusion from CFQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CFQ questionnaire. Score of cognitive emotion regulation from CERQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CERQ questionnaire. Score of cognitive avoidance from CAQ. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: CAQ questionnaire. Score of difficulties in emotion regulation from DERS. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: DERS questionnare. Score of anxiety sensitivity from ASI. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: ASI questionnaire. Score of Problem-solving from Tower of London. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Tower of London software. Score of inhibition from go/no go test. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Go/no go software. Score of working memory from n-back test. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: N- back software. University of Kurdistan Approved 2023-12-23 Ethics committee in biomedical research Pasdaran Blvd., University of Kurdistan., Central organization Sanandaj Kurdistan Iran (Islamic Republic of)